Kliniske studier sponset av Emergent Product Development Seattle LLC
Totalt 14 resultater
-
Emergent Product Development Seattle LLCAvsluttetMycosis Fungoides | Sezary syndromForente stater, Spania, Frankrike, Tyskland, Italia
-
PfizerEmergent Product Development Seattle LLCFullførtLeddgiktForente stater, Canada
-
PfizerEmergent Product Development Seattle LLCFullførtAktiv revmatoid artrittForente stater, Canada, Serbia, Japan, Spania, Polen, Ungarn, Argentina, Chile, Mexico
-
PfizerEmergent Product Development Seattle LLCFullførtLupus erythematosus, systemiskForente stater
-
PfizerEmergent Product Development Seattle LLCFullførtLeddgikt, revmatoidJapan
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCAvsluttet
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCAvsluttetSystemisk lupus erythematosusForente stater
-
GE HealthcarePharmaceutical Product Development, LLCFullførtKoronararteriesykdom (CAD)Forente stater, Tyskland, Sveits, Canada, Nederland, Frankrike, Finland
-
Seattle Children's HospitalFullførtSmerte | Spedbarn, nyfødte, sykdommer
-
Milliken Healthcare Products, LLCU.S. Army Medical Research and Development Command; Criterium, Inc.FullførtBrannsår | Hudforbrenning som krever hudtransplantasjonForente stater
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentFullført
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentFullført
-
Januario Castro, M.D.FDA Office of Orphan Products Development; Memgen, LLCAvsluttetKronisk lymfatisk leukemi | Lite lymfatisk lymfomForente stater
-
Georgetown UniversityJohns Hopkins Bloomberg School of Public Health; United States Agency for... og andre samarbeidspartnereRekrutteringOral pre-eksponeringsprofylakse (PrEP) | Langtidsvirkende injiserbart Cabotegravir for PrEPMalawi